Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) is a causative agent of severe-to-fatal pneumonia especially in patients with pre-existing conditions, such as smoking and chronic obstructive pulmonary disease (COPD). MERS-CoV transmission continues to be reported in the Saudi Arabian Peninsula since its discovery in 2012. However, it has rarely been epidemic outside the area except one large outbreak in South Korea in May 2015. The genome of the epidemic MERS-CoV isolated from a Korean patient revealed its homology to previously reported strains. MERS-CoV encodes 5 accessory proteins and generally, they do not participate in the genome transcription and replication but rather are involved in viral evasion of the host innate immune responses. Here we report that ORF8b, an accessory protein of MERS-CoV, strongly inhibits both MDA5- and RIG-I-mediated activation of interferon beta promoter activity while downstream signaling molecules were left largely unaffected. Of note, MDA5 protein levels were significantly down-regulated by ORF8b and co-expression of ORF4a and ORF4b. These novel findings will facilitate elucidation of mechanisms of virus-encoded evasion strategies, thus helping design rationale antiviral countermeasures against deadly MERS-CoV infection.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abdul-Rasool, S. and Fielding, B.C. 2010. Understanding human coronavirus HCoV-NL63. Open Virol. J. 4, 76–84.
Akira, S., Uematsu, S., and Takeuchi, O. 2006. Pathogen recognition and innate immunity. Cell 124, 783–801.
Alraddadi, B.M., Watson, J.T., Almarashi, A., Abedi, G.R., Turkistani, A., Sadran, M., Housa, A., Almazroa, M.A., Alraihan, N., Banjar, A., et al. 2016. Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg. Infect. Dis. 22, 49–55.
Banerjee, A., Falzarano, D., Rapin, N., Lew, J., and Misra, V. 2019. Interferon regulatory factor 3-mediated signaling limits Middle-East respiratory syndrome (MERS) coronavirus propagation in cells from an insectivorous bat. Viruses 11, 152.
Bradburne, A.F., Bynoe, M.L., and Tyrrell, D.A. 1967. Effects of a “new” human respiratory virus in volunteers. Br. Med. J. 3, 767–769.
Cardenas, W.B., Loo, Y.M., Gale, M.Jr., Hartman, A.L., Kimberlin, C.R., Martinez-Sobrido, L., Saphire, E.O., and Basler, C.F. 2006. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J. Virol. 80, 5168–5178.
Chan, J.F., Lau, S.K., To, K.K., Cheng, V.C., Woo, P.C., and Yuen, K.Y. 2015. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin. Microbiol. Rev. 28, 465–522.
Chan, C.P., Yuen, C.K., Cheung, P.H., Fung, S.Y., Lui, P.Y., Chen, H., Kok, K.H., and Jin, D.Y. 2018. Antiviral activity of double-stranded RNA-binding protein PACT against influenza A virus mediated via suppression of viral RNA polymerase. FASEB J. 32, 4380–4393.
Chau, T.L., Gioia, R., Gatot, J.S., Patrascu, F., Carpentier, I., Chapelle, J.P., O’Neill, L., Beyaert, R., Piette, J., and Chariot, A. 2008. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? Trends Biochem. Sci. 33, 171–180.
Cho, M. and Myoung, J. 2015. OX40 and 4-1BB downregulate Kaposi’s sarcoma-associated herpesvirus replication in lymphatic endothelial cells, but 4-1BB and not OX40 inhibits viral replication in B-cells. J. Gen. Virol. 96, 3635–3645.
Chowell, G., Abdirizak, F., Lee, S., Lee, J., Jung, E., Nishiura, H., and Viboud, C. 2015. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med. 13, 210.
Clement, J.F., Meloche, S., and Servant, M.J. 2008. The IKK-related kinases: from innate immunity to oncogenesis. Cell Res. 18, 889–899.
Comar, C.E., Goldstein, S.A., Li, Y., Yount, B., Baric, R.S., and Weiss, S.R. 2019. Antagonism of dsRNA-induced innate immune pathways by NS4a and NS4b accessory proteins during MERS coronavirus infection. mBio 10, e00319–19.
Corman, V.M., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach-Bludau, M., evan Boheemen, S., Gopal, R., Ballhause, M., Bestebroer, T.M., et al. 2012. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 17, pii:20285.
Fehr, A.R. and Perlman, S. 2015. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol. Biol. 1282, 1–23.
Fitzgerald, K.A., McWhirter, S.M., Faia, K.L., Rowe, D.C., Latz, E., Golenbock, D.T., Coyle, A.J., Liao, S.M., and Maniatis, T. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491–496.
Fung, I.C., Tse, Z.T., Chan, B.S., and Fu, K.W. 2015. Middle East respiratory syndrome in the Republic of Korea: transparency and communication are key. Western Pac. Surveill. Response J. 6, 1–2.
Gatot, J.S., Gioia, R., Chau, T.L., Patrascu, F., Warnier, M., Close, P., Chapelle, J.P., Muraille, E., Brown, K., Siebenlist, U., et al. 2007. Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J. Biol. Chem. 282, 31131–31146.
Goldstein, S.A. and Weiss, S.R. 2017. Origins and pathogenesis of Middle East respiratory syndrome-associated coronavirus: recent advances. F1000Res 6, 1628.
Gosert, R., Kanjanahaluethai, A., Egger, D., Bienz, K., and Baker, S.C. 2002. RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J. Virol. 76, 3697–3708.
Goubau, D., Schlee, M., Deddouche, S., Pruijssers, A.J., Zillinger, T., Goldeck, M., Schuberth, C., Van der Veen, A.G., Fujimura, T., Rehwinkel, J., et al. 2014. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates. Nature 514, 372–375.
Grandvaux, N., Servant, M.J., tenOever, B., Sen, G.C., Balachandran, S., Barber, G.N., Lin, R., and Hiscott, J. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76, 5532–5539.
Ha, S., Choi, I.S., Choi, C., and Myoung, J. 2016. Infection models of human norovirus: challenges and recent progress. Arch. Virol. 161, 779–788.
Hacker, H. and Karin, M. 2006. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, re13.
Hamre, D. and Procknow, J.J. 1966. A new virus isolated from the human respiratory tract. Proc. Soc. Exp. Biol. Med. 121, 190–193.
Hayman, D.T. 2016. Bats as viral reservoirs. Annu. Rev. Virol. 3, 77–99.
Ho, T.H., Kew, C., Lui, P.Y., Chan, C.P., Satoh, T., Akira, S., Jin, D.Y., and Kok, K.H. 2016. PACT- and RIG-I-dependent activation of type I interferon production by a defective interfering RNA derived from measles virus vaccine. J. Virol. 90, 1557–1568.
Honda, K., Takaoka, A., and Taniguchi, T. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349–360.
Honda, K. and Taniguchi, T. 2006. IRFs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6, 644–658.
Islam, M.N., Lee, K.W., Yim, H.S., Lee, S.H., Jung, H.C., Lee, J.H., and Jeong, J.Y. 2017. Optimizing T4 DNA polymerase conditions enhances the efficiency of one-step sequence- and ligation-independent cloning. Biotechniques 63, 125–130.
Jeong, J.Y., Yim, H.S., Ryu, J.Y., Lee, H.S., Lee, J.H., Seen, D.S., and Kang, S.G. 2012. One-step sequence- and ligation-independent cloning as a rapid and versatile cloning method for functional genomics studies. Appl. Environ. Microbiol. 78, 5440–5443.
Kang, S., Choi, C., Choi, I., Han, K.N., Rho, S.W., Choi, J., Kwon, J., Park, M.K., Kim, S.J., and Myoung, J. 2018. Hepatitis E virus methyltransferase inhibits type I interferon induction by targeting RIG-I. J. Microbiol. Biotechnol. 28, 1554–1562.
Kang, S. and Myoung, J. 2017a. Host innate immunity against hepatitis E virus and viral evasion mechanisms. J. Microbiol. Biotechnol. 27, 1727–1735.
Kang, S. and Myoung, J. 2017b. Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas. J. Microbiol. 55, 319–329.
Kang, H.S., Myoung, J., So, E.Y., Bahk, Y.Y., and Kim, B.S. 2016. Transgenic expression of non-structural genes of Theiler’s virus suppresses initial viral replication and pathogenesis of demyelination. J. Neuroinflammation 13, 133.
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K.J., Takeuchi, O., and Akira, S. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981–988.
Kew, C., Lui, P.Y., Chan, C.P., Liu, X., Au, S.W., Mohr, I., Jin, D.Y., and Kok, K.H. 2013. Suppression of PACT-induced type I interferon production by herpes simplex virus 1 Us11 protein. J. Virol. 87, 13141–13149.
Ki, M. 2015. 2015 MERS outbreak in Korea: hospital-to-hospital transmission. Epidemiol. Health 37, e2015033.
Kim, Y.J., Cho, Y.J., Kim, D.W., Yang, J.S., Kim, H., Park, S., Han, Y.W., Yun, M.R., Lee, H.S., Kim, A.R., et al. 2015. Complete genome sequence of Middle East respiratory syndrome coronavirus KOR/KNIH/002_05_2015, isolated in South Korea. Genome Announc. 3, e00787–15.
Kim, E. and Myoung, J. 2018. Hepatitis E virus papain-like cysteine protease inhibits type I interferon induction by down-regulating melanoma differentiation-associated gene 5. J. Microbiol. Biotechnol. 28, 1908–1915.
Kim, K.H., Tandi, T.E., Choi, J.W., Moon, J.M., and Kim, M.S. 2017. Middle East respiratory syndrome coronavirus (MERSCoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J. Hosp. Infect. 95, 207–213.
Kindler, E., Thiel, V., and Weber, F. 2016. Interaction of SARS and MERS coronaviruses with the antiviral interferon response. Adv. Virus Res. 96, 219–243.
Kok, K.H., Lui, P.Y., Ng, M.H., Siu, K.L., Au, S.W., and Jin, D.Y. 2011. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 9, 299–309.
Ksiazek, T.G., Erdman, D., Goldsmith, C.S., Zaki, S.R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J.A., Lim, W., et al. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953–1966.
Lau, S.K., Woo, P.C., Yip, C.C., Tse, H., Tsoi, H.W., Cheng, V.C., Lee, P., Tang, B.S., Cheung, C.H., Lee, R.A., et al. 2006. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J. Clin. Microbiol. 44, 2063–2071.
Lee, J.Y., Lee, J.S., Materne, E.C., Rajala, R., Ismail, A.M., Seto, D., Dyer, D.W., Rajaiya, J., and Chodosh, J. 2018. Bacterial RecA protein promotes adenoviral recombination during in vitro infection. mSphere 3, e00105–18.
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C., Epstein, J.H., Wang, H., Crameri, G., Hu, Z., Zhang, H., et al. 2005. Bats are natural reservoirs of SARS-like coronaviruses. Science 310, 676–679.
Lim, P.L. 2015. Middle East respiratory syndrome (MERS) in Asia: lessons gleaned from the South Korean outbreak. Trans. R. Soc. Trop. Med. Hyg. 109, 541–542.
Liu, S., Cai, X., Wu, J., Cong, Q., Chen, X., Li, T., Du, F., Ren, J., Wu, Y.T., Grishin, N.V., et al. 2015. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630.
Lui, P.Y., Wong, L.R., Ho, T.H., Au, S.W.N., Chan, C.P., Kok, K.H., and Jin, D.Y. 2017. PACT facilitates RNA-induced activation of MDA5 by promoting MDA5 oligomerization. J. Immunol. 199, 1846–1855.
Lundin, A., Dijkman, R., Bergstrom, T., Kann, N., Adamiak, B., Hannoun, C., Kindler, E., Jonsdottir, H.R., Muth, D., Kint, J., et al. 2014. Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the Middle East respiratory syndrome virus. PLoS Pathog. 10, e1004166.
Luthra, P., Sun, D., Silverman, R.H., and He, B. 2011. Activation of IFN-β expression by a viral mRNA through RNase L and MDA5. Proc. Natl. Acad. Sci. USA 108, 2118–2123.
Malathi, K., Dong, B., Gale, M.Jr., and Silverman, R.H. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448, 816–819.
Matthews, K.L., Coleman, C.M., van der Meer, Y., Snijder, E.J., and Frieman, M.B. 2014. The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. J. Gen. Virol. 95, 874–882.
Maxmen, A. 2017. Bats are global reservoir for deadly coronaviruses. Nature 546, 340.
Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449, 819–826.
Meyerholz, D.K., Lambertz, A.M., and McCray, P.B.Jr. 2016. Dipeptidyl peptidase 4 distribution in the human respiratory tract: Implications for the Middle East respiratory syndrome. Am. J. Pathol. 186, 78–86.
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., and Tschopp, J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172.
Motz, C., Schuhmann, K.M., Kirchhofer, A., Moldt, M., Witte, G., Conzelmann, K.K., and Hopfner, K.P. 2013. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science 339, 690–693.
Nam, H.S., Park, J.W., Ki, M., Yeon, M.Y., Kim, J., and Kim, S.W. 2017. High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea. Int. J. Infect. Dis. 58, 37–42.
Niemeyer, D., Zillinger, T., Muth, D., Zielecki, F., Horvath, G., Suliman, T., Barchet, W., Weber, F., Drosten, C., and Muller, M.A. 2013. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J. Virol. 87, 12489–12495.
Oh, M.D. 2016. The Korean Middle East respiratory syndrome coronavirus outbreak and our responsibility to the global scientific community. Infect. Chemother. 48, 145–146.
Park, M.K., Cho, H., Roh, S.W., Kim, S.J., and Myoung, J. 2019. Cell type-specific interferon-gamma-mediated antagonism of KSHV lytic replication. Sci. Rep. 9, 2372.
Park, Y.S., Lee, C., Kim, K.M., Kim, S.W., Lee, K.J., Ahn, J., and Ki, M. 2015. The first case of the 2015 Korean Middle East respiratory syndrome outbreak. Epidemiol. Health 37, e2015049.
Prins, K.C., Cardenas, W.B., and Basler, C.F. 2009. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J. Virol. 83, 3069–3077.
Prins, K.C., Delpeut, S., Leung, D.W., Reynard, O., Volchkova, V.A., Reid, S.P., Ramanan, P., Cardenas, W.B., Amarasinghe, G.K., Volchkov, V.E., et al. 2010. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. J. Virol. 84, 3004–3015.
Rota, P.A., Oberste, M.S., Monroe, S.S., Nix, W.A., Campagnoli, R., Icenogle, J.P., Penaranda, S., Bankamp, B., Maher, K., Chen, M.H., et al. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394–1399.
Runge, S., Sparrer, K.M., Lassig, C., Hembach, K., Baum, A., Garcia-Sastre, A., Soding, J., Conzelmann, K.K., and Hopfner, K.P. 2014. In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog. 10, e1004081.
Seth, R.B., Sun, L., Ea, C.K., and Chen, Z.J. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669–682.
Seys, L.J.M., Widagdo, W., Verhamme, F.M., Kleinjan, A., Janssens, W., Joos, G.F., Bracke, K.R., Haagmans, B.L., and Brusselle, G.G. 2018. DPP4, the Middle East respiratory syndrome coronavirus receptor, is upregulated in lungs of smokers and chronic obstructive pulmonary disease patients. Clin. Infect. Dis. 66, 45–53.
Siu, K.L., Yeung, M.L., Kok, K.H., Yuen, K.S., Kew, C., Lui, P.Y., Chan, C.P., Tse, H., Woo, P.C., Yuen, K.Y., et al. 2014. Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J. Virol. 88, 4866–4876.
Tyrrell, D.A. and Bynoe, M.L. 1965. Cultivation of a novel type of common-cold virus in organ cultures. Br. Med. J. 1, 1467–1470.
Vabret, A., Dina, J., Gouarin, S., Petitjean, J., Corbet, S., and Freymuth, F. 2006. Detection of the new human coronavirus HKU1: a report of 6 cases. Clin. Infect. Dis. 42, 634–639.
van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T.M., Raj, V.S., Zaki, A.M., Osterhaus, A.D.M.E., Haagmans, B.L., Gorbalenya, A.E., Snijder, E.J., et al. 2012. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3, e00473–12.
van den Brand, J.M., Smits, S.L., and Haagmans, B.L. 2015. Pathogenesis of Middle East respiratory syndrome coronavirus. J. Pathol. 235, 175–184.
van der Hoek, L., Pyrc, K., Jebbink, M.F., Vermeulen-Oost, W., Berkhout, R.J., Wolthers, K.C., Wertheim-van Dillen, P.M., Kaandorp, J., Spaargaren, J., and Berkhout, B. 2004. Identification of a new human coronavirus. Nat. Med. 10, 368–373.
Versteeg, G.A., Bredenbeek, P.J., van den Worm, S.H., and Spaan, W.J. 2007. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology 361, 18–26.
Weber, F., Wagner, V., Rasmussen, S.B., Hartmann, R., and Paludan, S.R. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80, 5059–5064.
Widagdo, W., Sooksawasdi Na Ayudhya, S., Hundie, G.B., and Haagmans, B.L. 2019. Host determinants of MERS-CoV transmission and pathogenesis. Viruses 11, 280.
Woo, P.C., Lau, S.K., Chu, C.M., Chan, K.H., Tsoi, H.W., Huang, Y., Wong, B.H., Poon, R.W., Cai, J.J., Luk, W.K., et al. 2005a. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol. 79, 884–895.
Woo, P.C., Lau, S.K., Tsoi, H.W., Huang, Y., Poon, R.W., Chu, C.M., Lee, R.A., Luk, W.K., Wong, G.K., Wong, B.H., et al. 2005b. Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J. Infect. Dis. 192, 1898–1907.
Yang, Y., Ye, F., Zhu, N., Wang, W., Deng, Y., Zhao, Z., and Tan, W. 2015. Middle East respiratory syndrome coronavirus ORF 4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets. Sci. Rep. 5, 17554.
Yang, Y., Zhang, L., Geng, H., Deng, Y., Huang, B., Guo, Y., Zhao, Z., and Tan, W. 2013. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell 4, 951–961.
Yip, C.W., Hon, C.C., Shi, M., Lam, T.T., Chow, K.Y., Zeng, F., and Leung, F.C. 2009. Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses. Infect. Genet. Evol. 9, 1185–1196.
Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D.M.E., and Fouchier, R.A.M. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814–1820.
Zhou, P., Fan, H., Lan, T., Yang, X.L., Shi, W.F., Zhang, W., Zhu, Y., Zhang, Y.W., Xie, Q.M., Mani, S., et al. 2018. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature 556, 255–258.
Zhou, H. and Perlman, S. 2007. Mouse hepatitis virus does not induce Beta interferon synthesis and does not inhibit its induction by double-stranded RNA. J. Virol. 81, 568–574.
Zielecki, F., Weber, M., Eickmann, M., Spiegelberg, L., Zaki, A.M., Matrosovich, M., Becker, S., and Weber, F. 2013. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J. Virol. 87, 5300–5304.
Zust, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B.W., Ziebuhr, J., Szretter, K.J., Baker, S.C., Barchet, W., Diamond, M.S., et al. 2011. Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat. Immunol. 12, 137–143.
Acknowledgements
This research was supported by HI15C3039 through the Korea Health Industry Development Institute (KHIDI) funded by the Korean Ministry of Health and Welfare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, J.Y., Bae, S. & Myoung, J. Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-β promoter activation: its implication for vaccine design. J Microbiol. 57, 803–811 (2019). https://doi.org/10.1007/s12275-019-9272-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-019-9272-7